Latest Commercialization News

Page 7 of 702
Optiscan Imaging has lodged a 510(k) submission for its InForm digital pathology device, moving the product from development into formal US regulatory assessment. FDA clearance is not assured, but a successful determination could open the door to commercial distribution in the company’s target market.
Victor Sage
Victor Sage
1 Oct 2026
BSA is proposing to acquire aerial infrastructure technology business Eonetics in a largely scrip-based transaction that would leave the sellers with about 39.9% of BSA. The deal remains non-binding, with one seller yet to sign and multiple approvals still required.
Victor Sage
Victor Sage
1 Oct 2026
Klevo Group has reported a sharp FY2026 turnaround, with revenue up 324%, positive operating cash flow and cash rising to A$4.32 million. The more striking claim is its KLVR stablecoin platform, which has recorded USD 59.2 million in unaudited revenue since trial commencement ahead of a planned commercial rollout.
Victor Sage
Victor Sage
1 Oct 2026
Prophecy International entered FY27 with sharply lower revenue, negative net assets and just $1 million in cash after a difficult restructuring year. Management has cut costs and launched its ProdataIQ AI product, but the auditor has warned of material uncertainty around the company's ability to continue as a going concern.
Sophie Babbage
Sophie Babbage
1 Oct 2026
Sunrise Energy Metals has told ASX that two December 2025 placements became proposed equity issues only after binding terms were executed and board approval obtained. The response comes after ASX questioned the timing of disclosure, the identity of the investor and sharp movements in SRL’s share price and trading volume.
Maxwell Dee
Maxwell Dee
1 Oct 2026
Quixxi has secured a four-year A$635,238 contract with a major Italian industrial group for its Clarity AI governance platform. The win strengthens the case for WhiteHawk’s proposed acquisition, but WhiteHawk will not benefit financially unless shareholders approve the deal and completion follows.
Victor Sage
Victor Sage
1 Oct 2026
Manuka Resources has received its first gold revenue after restarting processing at the Wonawinta plant in New South Wales. The company expects fortnightly gold revenue of A$3.0 million to A$4.0 million through the end of 2026, although sales remain dependent on the plant reaching steady state.
Maxwell Dee
Maxwell Dee
1 Oct 2026
Fulcrum Lithium has staked 41 additional claims around its Alkali Flats project in Nevada and reported up to 79% lithium extraction from acid-free roast and water-leach tests. The results improve on earlier water-leach work, although they remain below the company’s 93% to 96% sulfuric-acid benchmark and come from scoping-level tests.
Maxwell Dee
Maxwell Dee
1 Oct 2026
Group 6 Metals has posted a dramatic FY26 turnaround, with revenue reaching $129.0 million and net profit after tax rising to $148.2 million. The stronger balance sheet now faces its next test: converting stockpile-fed production and newly started underground mining into repeatable cash generation.
Maxwell Dee
Maxwell Dee
1 Oct 2026
FirstWave Cloud Technology has sharply reduced its FY26 loss and generated positive operating cash flow as network monitoring and Latin American revenue accelerated. But a $5.35 million net current asset deficiency, covenant breach and planned capital raise leave the turnaround dependent on continued execution.
Victor Sage
Victor Sage
1 Oct 2026
Nutritional Growth Solutions has completed its acquisition of Sprout Organic, installing founder Selasi Berdie as CEO and reshaping the group around infant, toddler and children’s nutrition. The deal lifts shares on issue to 964 million, while management targets A$870,000 in annualised savings.
Victor Sage
Victor Sage
1 Oct 2026
Prospect Resources has reported its first Phase 3 infill assays from Nyungu Central, including 18 metres at 1.31% copper, while extensional drilling continues to identify broad mineralisation beyond the existing resource. Twenty Nyungu Central assay results remain pending as the company advances toward a Q1 2027 Mumbezhi Scoping Study.
Maxwell Dee
Maxwell Dee
1 Oct 2026

Browse the archive

Full archive